Literature DB >> 15914638

Anastomotic vessels remain viable after photodynamic therapy in primate models of choroidal neovascularization.

Mark H Criswell1, Thomas A Ciulla, Lisa A Lowseth, Ward Small, Ronald P Danis, Dennis L Carson.   

Abstract

PURPOSE: Anastomotic vessels in exudative age-related macular degeneration (AMD) represent a serious clinical feature that reportedly does not respond well to either photocoagulation or photodynamic therapy (PDT). Anastomoses also occur in various animal models of choroidal neovascularization (CNV). In the present study, anastomotic vessels and their patency were evaluated in two primate CNV laser-trauma models after PDT, by using two novel photosensitizers.
METHODS: In cynomolgus (Macaca fascicularis) and squirrel (Saimiri sciureus) monkey eyes (n = 20), matrix placement of laser photocoagulation sites elicited CNV as a component of the development of fibrovascular tissue (FVT). FVT sites received PDT according to specific drug infusion and laser light treatment parameters. FVTs and anastomoses were evaluated by fundus photography, fluorescein angiography, and histologic examination.
RESULTS: Anastomoses averaged approximately 48% of FVT sites, with greatest occurrence in the macaque. Although PDT with each photosensitizer effectively produced FVT closure, both retinal vessels and anastomoses remained patent.
CONCLUSIONS: Although PDT is effective in closing the choroidal neovascularization in FVT, this technique was ineffective in occluding anastomotic vessels and their associated tributaries within the mid- to proximal retina. Various factors (vascular diameter, composition, blood flow, orientation) may contribute to continued anastomotic patency. By convention, such vessels would typically be defined as chorioretinal anastomoses (CRAs); however, continuing studies suggest the possibility that these neovessels constitute dual-origin hybrids. Regardless of origin, viable anastomoses provide one potential mechanism for revascularization to occur after PDT and may help to explain why CRAs are considered a poor prognostic sign in patients with AMD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15914638     DOI: 10.1167/iovs.04-1442

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  4 in total

1.  Polypoidal choroidal vasculopathy and retinochoroidal anastomosis in Japanese patients eligible for photodynamic therapy for exudative age-related macular degeneration.

Authors:  Ryo Obata; Yasuo Yanagi; Junko Kami; Hidenori Takahashi; Yuji Inoue; Yasuhiro Tamaki
Journal:  Jpn J Ophthalmol       Date:  2006 Jul-Aug       Impact factor: 2.447

Review 2.  Photodynamic Therapy for Cancer: What's Past is Prologue.

Authors:  Michael R Hamblin
Journal:  Photochem Photobiol       Date:  2020-01-07       Impact factor: 3.421

3.  Chorioretinal anastomosis and photodynamic therapy: a two-year follow-up study.

Authors:  Rufino M Silva; M Luz Cachulo; João Figueira; José R Faria de Abreu; J G Cunha-Vaz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08       Impact factor: 3.535

4.  Reduction of choroidal neovascularization via cleavable VEGF antibodies conjugated to exosomes derived from regulatory T cells.

Authors:  Ying Tian; Fan Zhang; Yefeng Qiu; Shuang Wang; Feng Li; Jiawei Zhao; Chao Pan; Yong Tao; Di Yu; Wei Wei
Journal:  Nat Biomed Eng       Date:  2021-07-26       Impact factor: 25.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.